pharma

Showing 15 posts of 2914 posts found.

takeda_global_hq

It’s official: Takeda to buy Shire for £46 billion

May 8, 2018
Manufacturing and Production, Sales and Marketing Shire, Takeda, acquisition, pharma

After more than a month of uncertainty, Takeda has finally confirmed it has managed to successfully acquire Shire, agreeing on …

opioid_therapy_credit_-_us_air_force_valerie_monroy

Los Angeles becomes latest US city to sue pharma over opioid crisis

May 4, 2018
Medical Communications, Sales and Marketing Los Angeles, opioid crisis, pharma

The city of Los Angeles has levied legal action against a number of pharmaceutical firms for their role in advancing …

baby-784607_960_720

Mallinckrodt gets two thumbs down from FDA for jaundice drug

May 4, 2018
Medical Communications, Sales and Marketing InfaCare, Mallinckrodt, biotech, drugs, pharma, pharmaceutical

Mallinckrodt paid $80 million, with a further $345 million dependent on milestones, to acquire InfaCare in the hope that the …

bms

BMS looks to leverage real-world data, with Flatiron collab

May 3, 2018
Medical Communications, Sales and Marketing Bristol-Myers Squibb, Flatiron health, biotech, drugs, pharma, pharmaceutical

Bristol-Myers Squibb has extended its existing collaboration with Flatiron Health by three years and expanded the efforts both will be …

sugar_tax

The UK sugar tax: A sweet or sour move?

May 3, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing UK, obesity, pharma, sugar tax

Dr Daniel Bailey, Senior Lecturer in Health, Nutrition and Exercise at the University of Bedfordshire, discusses the benefits of the …

nerves

New study argues the importance of existing anti-inflammatory drugs in fighting dementia

May 3, 2018
Research and Development Alzheimer's, dementia, pharma

Research into dementia has waned in recent times as researchers struggle to pin down concrete advancements, leading to the withdrawal …

ecstasy_monogram

Recreational drug MDMA proves efficacy in reducing PTSD symptoms, new study finds

May 3, 2018
Research and Development MDMA, PTSD, pharma

Promising new findings have been revealed in the efficacy of MDMA in treating post-traumatic stress disorder (PTSD).

veeva_event

Speakers Announced for Veeva R&D Summit, Europe

May 3, 2018
Medical Communications biotech, drugs, pharma, pharmaceutical, veeva

In the pharma industry, we tend to use a lot of acronyms. Even in every day life, we are shortening …

Sandoz US woes continue with biosimilar rejection

May 3, 2018
Sales and Marketing Novartis, Sandoz, biosimilars, biotech, drugs, pharma, pharmaceutical

In Novartis’ recently released Q1 results, which largely beat analysts’ estimates, Sandoz was a black spot on its record – …

jeremy_hunt

450,000 missed breast cancer screenings, 270 lives potentially shortened

May 2, 2018
Medical Communications Jeremy Hunt, NHS, UK, biotech, drugs, pharma, pharmaceutical

An error in the automated system left 450,000 women without an invite for breast screening and Jeremy Hunt, the UK’s …

BMS pulls the plug on Phase 3 trials of IDO1 inhibitor

May 2, 2018
Research and Development BMS, Bristol-Myers Squibb, IDO1, opdivo, pharma, phase 3

Bristol-Myers Squibb has terminated two pivotal Phase 3 trials of BMS-986205, an IDO1 inhibitor acquired through its $800 million acquisition …

20170628182643b6d1090b2-8235-4860-8281-743f52e15ed4

Samsung BioLogics’ shares down $6bn after accounting furore

May 2, 2018
Research and Development, Sales and Marketing Samsung BioLogics, Samsung Bioepis, biotech, drugs, pharma, pharmaceutical, south korea

Samsung BioLogics’ shares have been hit hard, after the South Korean company was handed a notice of suspected breach of …

aaron_traywick

Startup CEO who injected untested herpes cure during live stream found dead

May 2, 2018
Research and Development Aaron Traywick, Ascendance Biomedical, HIV, herpes, pharma

Aaron Traywick, the 28-year-old CEO of biotech startup Ascendance Biomedical who made headlines when he injected himself with an untested …

novartis_window

Novartis becomes first to gain second CAR T indication

May 2, 2018
Research and Development, Sales and Marketing Gilead, Kymriah, Novartis, Yescarta, biotech, drugs, pharma, pharmaceutical

Novartis has announced that its CAR T treatment, Kymriah, has successfully been given a second indication for the treatment of …

The Gateway to Local Adoption Series

Latest content